The store will not work correctly when cookies are disabled.
US9475795, 3
ID: ALA3981081
PubChem CID: 72548855
Max Phase: Preclinical
Molecular Formula: C18H22F3N3O4S
Molecular Weight: 433.45
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nn(C)c(C)c1S(=O)(=O)N1CCC(Oc2ccc(OC(F)(F)F)cc2)CC1
Standard InChI: InChI=1S/C18H22F3N3O4S/c1-12-17(13(2)23(3)22-12)29(25,26)24-10-8-15(9-11-24)27-14-4-6-16(7-5-14)28-18(19,20)21/h4-7,15H,8-11H2,1-3H3
Standard InChI Key: HRJWLVQPOCRWBC-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
3.1417 1.5281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0377 0.7299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5052 1.0408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2543 -0.2587 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4477 -0.3849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2499 -1.3728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4917 -2.5482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5988 -1.5004 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.5984 -2.7004 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6377 -2.1009 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2007 1.4909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4972 0.7364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4920 -0.7636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7876 -1.5212 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-7.7802 -3.0220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.8161 -3.6277 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-6.7379 -3.6166 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-7.7738 -4.2220 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-5.1903 -1.5091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8939 -0.7546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
4 6 1 0
6 7 1 0
6 8 2 0
8 2 1 0
8 9 1 0
9 10 2 0
9 11 2 0
9 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 12 1 0
15 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
24 25 1 0
24 26 1 0
24 27 1 0
22 28 1 0
28 29 2 0
29 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 433.45 | Molecular Weight (Monoisotopic): 433.1283 | AlogP: 3.17 | #Rotatable Bonds: 5 |
Polar Surface Area: 73.66 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.16 | CX LogP: 2.87 | CX LogD: 2.87 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.72 | Np Likeness Score: -1.64 |
References
1. (2016) Sulfonyl piperidine derivatives and their use for treating prokineticin mediated diseases, |